Guardant Health Inc (GH):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Guardant Health Inc (GH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10497
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection used during cancer treatment for residual disease monitoring and recurrence monitoring. Guardant Health also develops a cloud-based information platform for liquid biopsy-based genomic testing in cancer treatments. The company provides somatic alterations across all solid tumor sites. Guardant Health is headquartered in Redwood City, California, the US.

Guardant Health Inc (GH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guardant Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guardant Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Guardant Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guardant Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Guardant Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Guardant Health Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Guardant Health Raises USD360 Million in Venture Financing 11
Guardant Health Raises Funds in Series D Financing Round 13
Guardant Health Raises USD83 Million in Venture Financing 15
Guardant Health Raises USD50 Million in Series C Venture Financing 16
Guardant Health Raises USD56 Million in Venture Financing 17
Guardant Health Raises US$31.5 Million In Series B Venture Financing 18
Guardant Health Raises US$10 Million In Series A Financing Round 19
Partnerships 20
Guardant Health Enters into Agreement with Bristol-Myers 20
University of Texas MD Anderson Cancer Center Enters into Agreement with Guardant Health 21
Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 22
Guardant Health Enters into Distribution Agreement with IPS Genomix 23
Oncotest-Teva Enters into Distribution Agreement with Guardant Health 24
Guardant Health, Pangaea Biotech, Dr. Rosell Oncology Institute and Medica Scientia Innovation Research Enter into Agreement 25
Guardant Health Enters into Agreement with Principia Biopharma 26
Guardant Health Enters into Distribution Agreement with Sanomics 27
Guardant Health Enters into Agreement with Mirati Therapeutics 28
Equity Offering 29
Guardant Health Raises USD273.1 Million in IPO 29
Guardant Health Inc – Key Competitors 30
Guardant Health Inc – Key Employees 31
Guardant Health Inc – Locations And Subsidiaries 32
Head Office 32
Recent Developments 33
Legal and Regulatory 33
Jul 18, 2018: Foundation Medicine and Guardant Health Agree to Settle Patent Infringement Lawsuit 33
Product News 34
Dec 14, 2017: Liquid Biopsy Results Differed Substantially Between Two Providers 34
Other Significant Developments 35
Sep 05, 2018: Guardant Health reports cyber attack and information breach 35
Jun 03, 2017: Cure-One Announces Partnership with Guardant Health 36
May 11, 2017: Guardant Health Partners with SoftBank to Accelerate Efforts in Early Cancer Detection 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Guardant Health Inc, Medical Equipment, Key Facts, 2017 2
Guardant Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guardant Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Guardant Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guardant Health Inc, Deals By Market, 2012 to YTD 2018 8
Guardant Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Guardant Health Raises USD360 Million in Venture Financing 11
Guardant Health Raises Funds in Series D Financing Round 13
Guardant Health Raises USD83 Million in Venture Financing 15
Guardant Health Raises USD50 Million in Series C Venture Financing 16
Guardant Health Raises USD56 Million in Venture Financing 17
Guardant Health Raises US$31.5 Million In Series B Venture Financing 18
Guardant Health Raises US$10 Million In Series A Financing Round 19
Guardant Health Enters into Agreement with Bristol-Myers 20
University of Texas MD Anderson Cancer Center Enters into Agreement with Guardant Health 21
Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 22
Guardant Health Enters into Distribution Agreement with IPS Genomix 23
Oncotest-Teva Enters into Distribution Agreement with Guardant Health 24
Guardant Health, Pangaea Biotech, Dr. Rosell Oncology Institute and Medica Scientia Innovation Research Enter into Agreement 25
Guardant Health Enters into Agreement with Principia Biopharma 26
Guardant Health Enters into Distribution Agreement with Sanomics 27
Guardant Health Enters into Agreement with Mirati Therapeutics 28
Guardant Health Raises USD273.1 Million in IPO 29
Guardant Health Inc, Key Competitors 30
Guardant Health Inc, Key Employees 31

List of Figures
Guardant Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guardant Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Guardant Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guardant Health Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Guardant Health Inc (GH):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sebia SA:企業の製品パイプライン分析2018
    Summary Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers. The company's electrophoresis program offers automated system for capillary electrophoresis, gel electrophoresis and electrophoresis scanning software. It …
  • United Breweries Limited:企業の戦略・SWOT・財務情報
    United Breweries Limited - Strategy, SWOT and Corporate Finance Report Summary United Breweries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Coffee Republic Trading Ltd:企業の戦略・SWOT・財務情報
    Coffee Republic Trading Ltd - Strategy, SWOT and Corporate Finance Report Summary Coffee Republic Trading Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • CryoPort Inc (CYRX):企業の財務・戦略的SWOT分析
    CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Irkut Corporation (IRKT):企業の財務・戦略的SWOT分析
    Irkut Corporation (IRKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PNP Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PNP Therapeutics Inc (PNP Therapeutics) is a clinical-stage biopharmaceutical company that develops platform technology and products for the treatment of cancer. The company develops products for various types of cancer such as prostate, breast, colon, lung, brain, melanoma, kidney, ovarian, …
  • Icade SA:企業のM&A・事業提携・投資動向
    Icade SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Icade SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Astellas Pharma Inc.:企業の戦略・SWOT・財務情報
    Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report Summary Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bracket Global LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Bracket Global LLC (Bracket Global) is a clinical research organization that provides clinical technology solution that helps to improve clinical research experience. The organization’s Bracket eCOA is a flexible platform for electronic Clinical Outcomes Assessments that collects data from p …
  • Tech Mahindra Limited:企業の戦略・SWOT・財務分析
    Tech Mahindra Limited - Strategy, SWOT and Corporate Finance Report Summary Tech Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Split Rock Partners, LLC:企業の戦略・SWOT・財務分析
    Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report Summary Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Simona AG (SIM):企業の財務・戦略的SWOT分析
    Summary Simona AG (Simona) is a chemical company that manufactures and distributes chemicals and thermoplastic products. The company offers products such as pipes and fittings, semi-finished products, and finished parts, among others. Its semi-finished plastics include profiles, plates, rods, and we …
  • University of Texas MD Anderson Cancer Center:医療機器:M&Aディール及び事業提携情報
    Summary University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Ander …
  • Oxford Metrics plc (OMG):企業の財務・戦略的SWOT分析
    Oxford Metrics plc (OMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • SL Green Realty Corp:企業のM&A・事業提携・投資動向
    SL Green Realty Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SL Green Realty Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Ocean Power Technologies Inc (OPTT):電力:M&Aディール及び事業提携情報
    Summary Ocean Power Technologies, Inc. (OPT) is a provider of ocean energy solutions. The company harnesses the abundant wave power to draw out renewable energy; and commercializes ocean wave power conversion technology products. The company's PB3 PowerBuoy integrates patented technologies in hydrod …
  • Dermira Inc (DERM):医療機器:M&Aディール及び事業提携情報
    Summary Dermira Inc (Dermira) is a biopharmaceutical company that identifies, develops and commercializes therapeutic solutions for the treatment of dermatologic diseases, such as hyperhidrosis, acne vulgaris and atopic dermatitis. The company’s product includes QBREXZA (glycopyrronium) cloth, an an …
  • Woodside Petroleum Ltd (WPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Woodside Petroleum Ltd (Woodside) is an independent oil and gas company that explores, develops, produces and supplies energy. It explores and produces oil and gas from a portfolio of facilities in association with some of the world’s major oil and gas companies. The company operates liquefi …
  • Caleres Inc (CAL):企業の財務・戦略的SWOT分析
    Caleres Inc (CAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Heron Resources Ltd:企業の戦略・SWOT・財務分析
    Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆